OCA follow-up – Situation on December 30, 2022 Download PDF Antoine Balavoine2023-01-02T10:55:24+01:00December 30th, 2022|Other Regulated Information|
OCA follow-up – Situation on December 28, 2022 Download PDF Antoine Balavoine2022-12-28T18:55:38+01:00December 28th, 2022|Other Regulated Information|
Pixium Vision welcomes judgment by Paris Commercial Court against Second Sight Medical Products Download PDf Antoine Balavoine2022-12-27T22:54:06+01:00December 28th, 2022|News, Press Releases|
OCA follow-up – Situation on December 23, 2022 Download PDF Antoine Balavoine2022-12-26T12:14:20+01:00December 23rd, 2022|Other Regulated Information|
OCA follow-up – Situation on December 20, 2022 Download PDF Antoine Balavoine2022-12-21T10:29:41+01:00December 20th, 2022|Other Regulated Information|
PRIMAvera implantations now completed | 15 December 2022 Download PDF Antoine Balavoine2022-12-15T23:33:04+01:00December 15th, 2022|Broker Research|
OCA follow-up – Situation on December 15, 2022 Télécharger le PDF Antoine Balavoine2022-12-15T23:10:12+01:00December 15th, 2022|Other Regulated Information|
Completion of implantations in the European pivotal trial PRIMAvera Download PDF Antoine Balavoine2022-12-15T12:57:47+01:00December 15th, 2022|Press Releases|
OCA follow-up – Situation on December 12, 2022 Download PDF Antoine Balavoine2022-12-12T19:36:10+01:00December 12th, 2022|Other Regulated Information|
OCA follow-up – Situation on December 6, 2022 Download PDF Antoine Balavoine2022-12-07T00:16:30+01:00December 6th, 2022|Other Regulated Information|